Jane Wasman is President at ACORDA THERAPEUTICS INC (ACOR). They have made 8 open-market trades across 2 companies since 2006, most recently 2026-05-15.
CIK 0001352455
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $34K since 2025, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLS | BUY | 2025-05-30 | 2025-06-02 | $1.69 | $34K | +1.9% | +30.9% | +13.0% |
| ACOR | SELL · 10b5-1 | 2019-12-02 | 2019-12-04 | $1.60 | $4K | -7.7% | +24.0% | -32.8% |
| ACOR | SELL | 2018-12-03 | 2018-12-06 | $20.52 | $126K | -15.8% | -12.6% | -26.9% |
| ACOR | SELL | 2018-01-19 | 2018-01-23 | $27.59 | $1.9M | -8.8% | -5.0% | -16.0% |
| ACOR | SELL | 2017-12-01 | 2017-12-05 | $20.52 | $187K | +3.2% | +3.2% | +27.2% |
| ACOR | SELL | 2017-02-09 | 2017-02-13 | $22.30 | $2.4M | +5.3% | +18.8% | -33.8% |
| ACOR | SELL | 2016-12-01 | 2016-12-05 | $20.73 | $137K | +0.7% | -3.5% | +27.8% |
| ACOR | SELL | 2016-10-03 | 2016-10-05 | $20.78 | $78K | -3.3% | -17.5% | -4.8% |
| ACOR | SELL · 10b5-1 | 2016-09-23 | 2016-09-27 | $27.32 | $14K | -10.9% | -18.0% | -17.5% |
| ACOR | SELL · 10b5-1 | 2015-12-23 | 2015-12-28 | $43.10 | $463K | -8.7% | -10.0% | -39.5% |
| ACOR | SELL · 10b5-1 | 2015-12-22 | 2015-12-24 | $42.43 | $585K | -8.7% | -5.0% | -38.7% |
| ACOR | SELL · 10b5-1 | 2015-12-21 | 2015-12-22 | $42.00 | $34K | -8.7% | -10.6% | -38.2% |
| ACOR | SELL · 10b5-1 | 2015-12-17 | 2015-12-21 | $40.00 | $131K | -8.7% | -9.5% | -38.2% |
| ACOR | SELL · 10b5-1 | 2015-12-01 | 2015-12-03 | $38.08 | $210K | -8.7% | +0.7% | -15.3% |
| ACOR | SELL · 10b5-1 | 2015-10-05 | 2015-10-06 | $31.75 | $119K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-12-01 | 2014-12-03 | $35.58 | $247K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-11-03 | 2014-11-05 | $34.84 | $520K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-10-03 | 2014-10-07 | $34.13 | $128K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-09-24 | 2014-09-26 | $36.00 | $537K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-08-27 | 2014-08-29 | $33.00 | $492K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $33.52 | $282K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2013-10-03 | 2013-10-07 | $35.74 | $134K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2012-12-03 | 2012-12-05 | $24.20 | $170K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2011-12-01 | 2011-12-05 | $22.92 | $168K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2010-12-01 | 2010-12-03 | $26.53 | $199K | -8.7% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.